Skip to content
Independent analysis of NHS open data
PharmaInsight

Ofatumumab

Malignant Disease and Immunosuppression Drugs affecting the immune response BNF 0802040BD
Data updated March 2026 Download CSV
1items

Dispensed in March 2026

8items

Rolling 12 months

£1,493

Net ingredient cost · March 2026

Figure 1. Ofatumumab: national items dispensed by month

0 1.5 3 Oct 2025 Dec 2025 Jan 2026 Feb 2026 Mar 2026 1 Oct 2025: 1 Dec 2025: 3 Jan 2026: 1 Feb 2026: 2 Mar 2026: 1

Source: NHSBSA Prescription Cost Analysis, to March 2026

Download CSV
Embed this chart

At a glance

  • Therapeutic class Drugs affecting the immune response
  • Presentations 1 shown
  • Average cost / item £1,492.50
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, March 2026

The individual products dispensed under Ofatumumab this month.

Presentations of Ofatumumab, March 2026
Presentation BNF code Items Net ingredient cost
Kesimpta Sensoready 20mg/0.4ml inj pre-filled pens 0802040BDBBAAAA 1 £1,493

Source: NHSBSA Prescription Cost Analysis · to March 2026 OGL v3.0

Where Ofatumumab is dispensed

The regions and dispensing practices with the highest Ofatumumab volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Ofatumumab is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Ofatumumab with

Other medicines in the same BNF section, by prescribing volume.